Andreas Rimner, MD, is the Director of Thoracic Radiation Oncology Research and Associate Attending at Memorial Sloan Kettering Cancer Center specialized in treating thoracic malignancies, including non-small cell lung cancer (NSCLC) and small cell lung cancer, malignant pleural mesothelioma (MPM), thymic tumors and metastatic disease. He is the Past Thoracic Track Chair of the Annual Meeting of ASTRO, ABR board member for Thoracic Cancers and Sarcomas, Vice President of ITMIG, Board Member of IMIG and Member of the IASLC Staging and Prognostic Factors Committee. He is the Principal Investigator of 8 ongoing prospective clinical trials. He is a Member of the Lung Core Committee of NRG Oncology and the national Principal Investigator of a phase III NRG Oncology trial (NRG LU-006) on the role of hemithoracic pleural IMPRINT in patients with resectable malignant pleural mesothelioma.